saxenda glp 1 agonist (liraglutide) GLP-1 Medications for Weight Loss
Description
Endocrinol Metab (Seoul) 2021;36:64760.ArticlePubMedPMC 13
Consistent with the known effects and common side effects of semaglutide, more participants receiving active medication reported decreased appetite as well as increased nausea and constipation
Weight loss compared to placebo was ~5% in RCTs
Oxygen consumption (VO 2 ), carbon dioxide production (VCO 2 ), RER, energy expenditure (kcal h 1 ) and locomotor activity (cm s 1 ) were recorded and collected in 15 min bins
Patients fill out a questionnaire and consult with Ro providers about treatment goals and clinical needs
& Dutta, D
